InfuSystem Holdings, Inc.

AMEX:INFU

Medical - Instruments & Supplies

Healthcare
$14.67 +4.00%

+$0.35 today

Market cap
$293.89M
Beta
1.42
P/E (TTM)
23.2
EPS (TTM)
$0.39
52W Low $5.38High $11.04

Volume 0.16M

Average 0.16M

INFU Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

InfuSystem Holdings, Inc.AMEX: INFU

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables grows, but more slowly than its trailing trend

Q1 FY2026 accounts payables of $3.33M (cash outflow) rose 111.0% year over year, behind the +114.4% change in trailing-twelve-month accounts payables. Sequentially, it rose 478.8% from the prior quarter.

Context

  • Accounts payables amounted to 0.5% of revenue in FY2025, unchanged from a year earlier.
  • Accounts payables increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +111.0% toward the trailing-twelve-month pace of +114.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$3.33M+478.8% QoQ
Last fiscal yearDec 2025
-$708K+4.7% YoY
LTMMar 2026
-$2.46M+114.4% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+111.0%——
1 year+4.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
(708K) USD
Year-over-year change
-4.7%

Accounts Payables vs competitors

How INFU compares with its peers on the latest reported figures

  • INFU's LTM Mar 2026 accounts payables of $2.46M is the 2nd largest of the 3 companies compared; the peer median is $5.38M.
  • Its year-over-year change of +114.4% is the 2nd highest of 3, against a peer median of +352.4%.
  • Accounts payables amounts to 1.7% of revenue for INFU, versus a peer median of 2.1%.
INFU Competitors Peer median
Accounts Payables for INFU and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ICUIICU Medical, Inc.LTM Jun 2026$12.29M -170.3%-42.8%0.6%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$2.46M +114.4%—1.7%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$1.54M +875.1%-19.1%3.6%
Peer median (excluding INFU) $5.38M+352.4%-30.9%2.1%

Competitors are the stored peer set for INFU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.42M18K872K2.35M6.63M
Depreciation & Amortization14.63M13.36M12.51M12.5M13.29M
Deferred Income Tax(153K)19K633K1.92M2.73M
Stock-Based Compensation6.4M3.83M4.07M4.46M4.36M
Change in Working Capital(2.69M)385K(5.56M)652K(94K)
Accounts Receivables829K(1.15M)(2.36M)(701K)263K
Inventory(864K)(882K)(1.58M)(126K)1.14M
Accounts Payables(2.36M)2.94M2.42M(676K)(708K)
Other Working Capital(294K)(522K)(4.03M)2.16M(789K)
Other Non-Cash Items(1.29M)(90K)(1.3M)(1.42M)(2.51M)
Operating Cash Flow18.32M17.52M11.22M20.46M24.41M
Capital Expenditures(16.66M)(15.08M)(11.12M)(17.83M)(560K)
Acquisitions (Net)(7.98M)3.6M4.38M4.59M(1.41M)
Purchases of Investments0(14.09M)000
Sales of Investments010.5M000
Other Investing Activities3.32M3.6M4.38M(12.15M)(4.82M)
Investing Cash Flow(21.32M)(11.48M)(6.73M)(13.24M)(6.79M)
Debt Repayment(5.47M)(13K)(3.95M)(5.32M)(4.32M)
Common Stock Issued0000335K
Common Stock Repurchased(1.73M)(6.65M)(1.31M)(2M)(10.97M)
Dividends Paid00000
Other Financing Activities738K605K835K387K0
Financing Cash Flow(6.46M)(6.06M)(4.42M)(6.92M)(14.96M)
Effect of Forex Changes00000
Net Change in Cash(9.46M)(21K)66K296K2.66M
Free Cash Flow1.66M2.44M106K2.63M23.85M

InfuSystem Holdings, Inc.

AMEX:INFU

Intrinsic Alpha fair value

Locked

Current Price

$14.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.